Cambridge Epigenetix raised €4.4M in a Series A round in Oct 2014. The company is based in Cambridge, UK. Investors in the round: Cambridge Enterprise, New Science Ventures, Syncona Partners. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
